Literature DB >> 28291707

Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods.

Nadiya Khyzha1, Azad Alizada2, Michael D Wilson3, Jason E Fish4.   

Abstract

Atherosclerosis is a vascular pathology characterized by inflammation and plaque build-up within arterial vessel walls. Vessel occlusion, often occurring after plaque rupture, can result in myocardial and cerebral infarction. Epigenetic changes are increasingly being associated with atherosclerosis and are of interest from both therapeutic and biomarker perspectives. Emerging genomic approaches that profile DNA methylation, chromatin accessibility, post-translational histone modifications, transcription factor binding, and RNA expression in low or single cell populations are poised to enhance our spatiotemporal understanding of atherogenesis. Here, we review recent therapeutically relevant epigenetic discoveries and emerging technologies that may generate new opportunities for atherosclerosis research.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  atherosclerosis; endothelial; epigenetics; inflammation; transcription

Mesh:

Substances:

Year:  2017        PMID: 28291707     DOI: 10.1016/j.molmed.2017.02.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  67 in total

1.  Long Noncoding RNA-CERNA1 Stabilized Atherosclerotic Plaques in apolipoprotein E-/- Mice.

Authors:  Wei Lu; Xiaoying He; Le Su; Junying Miao
Journal:  J Cardiovasc Transl Res       Date:  2019-03-19       Impact factor: 4.132

2.  Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.

Authors:  Tamas Kiss; Cory B Giles; Stefano Tarantini; Andriy Yabluchanskiy; Priya Balasubramanian; Tripti Gautam; Tamas Csipo; Ádám Nyúl-Tóth; Agnes Lipecz; Csaba Szabo; Eszter Farkas; Jonathan D Wren; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

3.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 4.  Pathophysiology of cardiovascular disease in diabetes mellitus.

Authors:  Gerardo Rodriguez-Araujo; Hironori Nakagami
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-02-14

Review 5.  Epigenetic Regulation of Vascular Diseases.

Authors:  Abdalrahman Zarzour; Ha Won Kim; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

Review 6.  Atherosclerosis Is an Epigenetic Disease.

Authors:  Suowen Xu; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Trends Endocrinol Metab       Date:  2018-05-10       Impact factor: 12.015

Review 7.  Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy.

Authors:  Jacob B Pierce; Mark W Feinberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-23       Impact factor: 8.311

8.  High-fat diet-induced GAIT element-mediated translational silencing of mRNAs encoding inflammatory proteins in macrophage protects against atherosclerosis.

Authors:  Abhijit Basu; Nina Dvorina; William M Baldwin; Barsanjit Mazumder
Journal:  FASEB J       Date:  2020-03-30       Impact factor: 5.191

9.  Atherosclerosis-associated differentially methylated regions can reflect the disease phenotype and are often at enhancers.

Authors:  Michelle Lacey; Carl Baribault; Kenneth C Ehrlich; Melanie Ehrlich
Journal:  Atherosclerosis       Date:  2018-11-27       Impact factor: 5.162

10.  Global DNA methylation in rats´ liver is not affected by hypercholesterolemic diet.

Authors:  L Jurcikova-Novotna; L Mrazova; K Mičová; D Friedecký; J A Hubacek; R Poledne
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.